INTRODUCTION
============

The landscape of each chromosome emanates from an intricate nucleoprotein complex referred to as the nucleosome. Composed of two copies each of histone H3, H4, H2A and H2B and wrapped by a DNA fragment ∼146 bp, this protein--DNA complex constitutes the first step of DNA compaction and plays an important role in controlling the access of different DNA-binding machineries to various regions of chromosomes. This process is dynamically regulated by ATP-dependent chromatin remodelers along with histone-modifying enzymes and regulates a myriad of biological processes including, but not limited to, chromosome silencing, transcription, DNA replication and DNA damage repair ([@gkr1235-B1]).

Several post-translational modifications such as acetylation, phosphorylation, ubiquitylation/sumoylation, ADP ribosylation, PARylation and methylation, have been mapped onto histone proteins and linked to various cellular functions ([@gkr1235-B2]). Of interest, methylation of lysine residues by SET domain proteins (Suppressor of Variegation 3--9, Enhancer of Zeste and Trithorax) that frequently exhibits preference towards a precise residue and has the ability to transfer up to three methyl groups to a lysine ε-amine, has been linked to important biological processes. Notably, systematic mapping of methyl--lysine marks on histone H3 demonstrated that histone H3 Lys-4 mono-, di- and tri-methylation (H3K4me1/2/3) decorate the promoter and strong enhancer regions of actively transcribed genes. The same study also showed that H3K4me1 localizes to poised enhancers and chromatin regions undergoing transcriptional transition ([@gkr1235-B3],[@gkr1235-B4]). These results further support initial findings linking H3K4 methylation with promoter regions of actively transcribed genes ([@gkr1235-B5; @gkr1235-B6; @gkr1235-B7]).

In the budding yeast *Saccharomyces cerevisiae*, the COMPlex ASsociated with SET1 (COMPASS) ([@gkr1235-B8],[@gkr1235-B9]) is the sole protein catalyzing H3K4 methylation whereas in mammals, this reaction is catalyzed by at least six members: MLL1-4, SET1A and SET1B. Each mammalian methyltransferase assembles in a COMPASS-like complex and despite sharing similarities in substrate specificity, the SET1 lysine methyltransferases (KMTs) are not functionally redundant ([@gkr1235-B10; @gkr1235-B11; @gkr1235-B12; @gkr1235-B13; @gkr1235-B14; @gkr1235-B15; @gkr1235-B16]), and, correlatively, binding studies have demonstrated that members of the SET1 family interact with unique subsets of proteins. The KMTs MLL2 and MLL3 have been shown to interact with activating signal cointegrator 2 ([@gkr1235-B17]) while WDR82 and menin associate with SET1A/SET1B ([@gkr1235-B18; @gkr1235-B19; @gkr1235-B20]) and MLL1/MLL2 ([@gkr1235-B11],[@gkr1235-B15]), respectively. Despite these differences, members of the SET1 family share several features including the complexity of their domain organization and the presence of a catalytic SET domain. In addition, all but MLL5 associate with a three-subunit complex composed of WD-repeat protein-5 (WDR5), retinoblastoma-binding protein-5 (RbBP5) and absent, small, homeotic disks-2-like (ASH2L), collectively referred to as the MLL core complex ([@gkr1235-B21],[@gkr1235-B22]), which is required for the stimulation of MLL1 di-/tri-methyltransferase activity both *in vitro* ([@gkr1235-B23]) and *in vivo* ([@gkr1235-B22],[@gkr1235-B24]).

Biochemical and structural studies have recently assigned discrete functions to RbBP5, ASH2L and WDR5 in the assembly of the core complex and stimulation of MLL1 KMT activity. Apart from its DNA binding domain ([@gkr1235-B25],[@gkr1235-B26]), ASH2L binds RbBP5 via its SPIa and ryanodine receptor domain and the ASH2L/RbBP5 heterodimer stimulates MLL1 methyltransferase activity ([@gkr1235-B27]). In addition to its ASH2L-interacting region, RbBP5 comprises residues that directly bind WDR5, an interaction important for maintaining the integrity of the core complex and indirectly the stimulation of MLL1 KMT activity ([@gkr1235-B28],[@gkr1235-B29]). On the opposite side of the WDR5 β-propeller domain, WDR5 binds a small motif preceding the SET domain of MLL1 ([@gkr1235-B23],[@gkr1235-B30]). Also referred to as the WDR5-interacting motif (Win), the interaction between the MLL1 Win motif (MLL1~Win~) and WDR5 is important in the scaffolding of the MLL1--WDR5--RbBP5--ASH2L complex and stimulation of MLL1 KMT activity *in vitro* ([@gkr1235-B23]). Based on these findings and sequence homology between the Win motifs, the same authors surmised that WDR5 would play an analogous role in binding the other members of the SET1 family, namely MLL2-4, SET1A and SET1B ([@gkr1235-B31]).

We herein provide biochemical evidence demonstrating that WDR5 binds, with different equilibrium dissociation constants, peptides corresponding to the Win motifs of the other SET1 family members. Correspondingly, the crystal structures of WDR5 in complex with MLL2-4, SET1A and SET1B Win motifs reveal that WDR5 accommodates the different Win motifs using divergent networks of hydrogen bonds and hydrophobic contacts. Finally, we show that WDR5, when in complex with the ASH2L-RbBP5 heterodimer, is important for the full stimulation of MLL1-4, SET1A and SET1B methyltransferase activity. Overall, these findings further support the fundamental role of WDR5 in scaffolding the SET1 complexes and indirect stimulation of H3K4 methylation.

MATERIALS AND METHODS
=====================

Protein purification
--------------------

Constructs corresponding to the Win and SET domains of MLL1 (3745--3969), MLL2 (5344--5536) and MLL4 (2512--2715) were cloned into a pGST-based vector while those for MLL3 (4714--4911), SET1A (1487--1707) and SET1B (1701--1923) were cloned in a home-made vector (pSMT3). MLL1 and MLL3 were overexpressed as GST and His-SUMO fusion proteins, respectively, in Rosetta cells (Novagen) with 0.1 mM IPTG for 16 h at 18°C. Due to their poor solubility, MLL2, MLL4, SET1A and SET1B were overexpressed in Arctic cells (Stratagene) with 1 mM IPTG for 48 h at 10°C. Cells were harvested in either 50 mM sodium phosphate pH 7.0, 500 mM sodium chloride and 5 mM β-mercaptoethanol (pSMT3) or phosphate buffered saline (pGST), lysed by sonication, clarified by centrifugation and filtration, purified by affinity chromatography and ULP1- (pSMT3) or TEV- (pGST2) cleaved on beads for 16 h at 4°C. Following cleavage, the enzymes were dialyzed into a final buffer of 20 mM Tris--HCl pH 7.5, 300 mM sodium chloride and 5 mM β-mercaptoethanol. The members of the core complex, including ASH2L, RbBP5 and WDR5 (S22--334) were overexpressed and purified as previously described ([@gkr1235-B33]). Following gel filtration, the core complex subunits were dialyzed in 20 mM Tris--HCl pH 7.5, 300 mM sodium chloride and 5 mM β-mercaptoethanol. The concentrations of SET1 proteins were quantified either by UV or coomassie-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS--PAGE) gel.

Isothermal titration calorimetry
--------------------------------

Isothermal titration calorimetry (ITC) experiments were performed using a VP-ITC calorimeter (MicroCal) as previously described ([@gkr1235-B29],[@gkr1235-B33]). Briefly, a solution of peptide (0.5--1 mM) derived from the Win motif of MLL1, MLL2, MLL3, MLL4, SET1A or SET1B was injected into a solution of WDR5 (0.06 mM). Titrations were performed at 19°C in 20 mM sodium phosphate pH 7.0, 100 mM NaCl and 5 mM β-mercaptoethanol. To decrease the rate of saturation of WDR5 peptidyl-arginine-binding cleft, the volume of injection of the MLL4~Win~ peptide was decreased by half (from 10 to 5 µl) for injections 9--19. Titration curves were analyzed using the Origin software.

Protein crystallization, data collection and structure determination
--------------------------------------------------------------------

Equimolar amounts of purified WDR5 and the Win peptides were incubated on ice for 1 h and crystallized using the sitting- or hanging-drop vapor diffusion methods. Crystals of WDR5--Win complexes were obtained in conditions shown in [Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1235/DC1). Briefly, crystallization conditions for each complex vary but the predominant components in the mother liquors are ammonium sulfate and polyethylene glycol 3350. Crystals were sequentially soaked in the mother liquor supplemented with 5, 10, 15 and 20% of glycerol, harvested and flash frozen in liquid nitrogen. Data sets were collected at the Life Science Collaborative Access Team (LS-CAT) beamline at the Advance Photon Source of the Argonne National Laboratory and indexed with HKL2000 ([@gkr1235-B34]). The structure of each WDR5--Win complex was solved by molecular replacement using Phaser and apo-WDR5 as a search model (RCSB 2H13.pdb) ([@gkr1235-B35]). The structure of each WDR5--Win complex was further improved using iterative cycles of refinement, using either Refmac ([@gkr1235-B36]) or Buster ([@gkr1235-B37]) and model building with COOT ([@gkr1235-B38]). The quality of the structures was validated using Molprobity ([@gkr1235-B39]).

*In vitro* methyltransferase assay
----------------------------------

Methyltransferase assays were performed as previously described ([@gkr1235-B29],[@gkr1235-B33]). Briefly, each recombinantly purified SET1 KMT was incubated with equimolar amounts of WDR5, RbBP5 and ASH2L in 50 mM Tris pH 8.0, 200 mM NaCl, 3 mM Dithiothreitol (DTT), 5 mM MgCl~2~, 5% glycerol and 1 mM histone H3 or peptide corresponding to the first N-terminal 15 residues or 10 µM of recombinantly purified H3. Reactions were initiated by adding 1 µCi of radiolabeled *S*-adenosyl-[l]{.smallcaps}-methionine (AdoMet) (0.07 mM of tritiated AdoMet) and stopped by spotting the reactions onto Whatman P-81 filter papers. Free AdoMet was removed by washing the filter papers four times in 250 ml of 50 mM sodium bicarbonate pH 9.0 and methyltransferase activity was quantified by liquid scintillation counting.

RESULTS
=======

Equilibrium dissociation constants of the Win motifs for WDR5
-------------------------------------------------------------

A recent biochemical analysis of WDR5 peptidyl-arginine-binding cleft revealed that this protein binds a 10-residue peptide corresponding to MLL1~Win~ with an equilibrium dissociation constant (*K*~D~) of 1.7 µM. The crystal structure of WDR5 in complex with MLL1~Win~ identified that R3765 of MLL1 was critical in conferring binding to WDR5, scaffolding the MLL1--WDR5--RbBP5--ASH2L complex and, correlatively, stimulation of MLL1 methyltransferase activity ([@gkr1235-B23]). Accordingly, the same authors posited that a similar region found on other members of the SET1 family would play an analogous role ([@gkr1235-B31]) while another study proposed that only MLL1 and MLL4 could bind WDR5 ([@gkr1235-B30]). In order to investigate these hypotheses, we first sought to measure the *K*~D~ values of WDR5 for MLL1-4 and SET1A/BWin motifs. Using ITC, we determined that WDR5 binds MLL1 ~Win~ and MLL4~Win~ peptides with a *K*~D~ of 1.13 µM and 0.03 µM, respectively. Similar titration experiments of WDR5 with MLL2~Win~ and MLL3~Win~ peptides resulted in *K*~D~ of 0.16 µM and 2.03 µM, respectively, while SET1A~Win~ and SET1B~Win~ peptides bound to WDR5 with a *K*~D~ of 0.26 µM and 0.10 µM, respectively. Overall, these results demonstrate that WDR5 binds the Win region of all the members of the SET1 family of KMTs. However, given the divergence in the amino acid sequence succeeding the conserved arginine residue and the ∼37-fold range of binding affinities of WDR5 for the Win motifs ([Table 1](#gkr1235-T1){ref-type="table"} and [Figure 1](#gkr1235-F1){ref-type="fig"}), our binding analysis suggests that WDR5 interacts with SET1 KMTs using divergent modes. Figure 1.WDR5 binds MLL1-4, SET1A and SET1B Win motifs. ITC titration experiments with MLL1~Win~ (**A**), MLL2~Win~ (**B**), MLL3~Win~ (**C**), MLL4~Win~ (**D**), SET1A~Win~ (**E**) and SET1B~Win~ (**F**) peptides and WDR5 (upper trace) and the fitted binding curve (lower trace). The sequence of the Win motifs and the *K*~D~ are indicated as insets. Titration of WDR5 with Win peptides displays binding stoichiometries (*N* values) between 0.9 and 1.0. Table 1.Alignment of SET1 Win motifsAmino acid sequenceWin motifsP~−3~P~−2~P~−1~P~0~P~+1~P~+2~P~+3~P~+4~P~+5~P~+6~P~+7~MLL1~Win~G~3762~SARAEVHLRKMLL2~Win~G~5062~CARSEPKILTMLL3~Win~G~4707~S!ARAEPKM[^a^](#gkr1235-TF1){ref-type="table-fn"}[SA]{.ul}MLL4~Win~G~2508~AARAEVYLR[K]{.ul}SET1A~Win~G~1492~SARSEGY[YPI]{.ul}SET1B~Win~[G]{.ul}~1882~CARSEGFYT[I]{.ul}[^1][^2]

Crystal structures of the WDR5--MLL~Win~ complexes
--------------------------------------------------

To gain insights into the mechanisms underlying WDR5 ability to bind the structurally divergent C-terminal ends of the Win peptides ([Table 1](#gkr1235-T1){ref-type="table"}), we determined the crystal structures of WDR5 in complex with peptides corresponding to the Win motifs of MLL2 (1.4 Å resolution), MLL3 (2.2 Å resolution), MLL4 (1.57 Å resolution), SET1A (2.1 Å resolution) and SET1B (2.2 Å resolution) ([Supplementary Table S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1235/DC1)). The WDR5--Win complexes superimpose with overall r.m.s.d. of \< 0.3 Å for all aligned atoms, showing that binding of the Win peptides does not result in noticeable changes in the overall structure of WDR5. Simulated annealing omit maps revealed clear electron density for several residues flanking the central arginine residue of each Win motif ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gkr1235/DC1)). However, the distal residues in the peptides, including the M4715 side chain (single letter code refer to residues of the Win motifs), S4716 and A4717 of MLL3~Win~, K2518 of MLL4~Win~, P1501 and I1502 of SET1A~Win~ and G1882 and I1892 as well as the side chains of F1889 and Y1890 of SET1B~Win~ lack interpretable electronic density and were not modeled. Close inspection of the WDR5-Win structures reveals that all the peptides bind WDR5 peptidyl-arginine-binding cleft, a crevice located on one side of the WDR5 β-propeller structure ([Figure 1](#gkr1235-F1){ref-type="fig"}), in which each peptide engages in several hydrogen bonds, van der Waals contacts and hydrophobic interactions with WDR5. To facilitate the discussion of the interactions between WDR5 and the Win motifs, we have used a modified version of the Schechter--Berger notation for assigning residues of the Win motifs in which the central arginine residue is denoted as P~0~ ([Table 1](#gkr1235-T1){ref-type="table"}). In addition, interactions between WDR5 and the Win motifs have been separated into two categories based on interactions with residues preceding and succeeding the P~+2~ glutamate residue of the Win motifs ([Table 1](#gkr1235-T1){ref-type="table"}).

Consistent with the sequence homology of residues flanking the central arginine (P~0~), including those at P~−3~, P~−2~, P~−1~, P~+1~ and P~+2~ positions ([Table 1](#gkr1235-T1){ref-type="table"}), this region of the peptide adopts similar orientations and engages in several shared direct and water-mediated hydrogen bonds and hydrophobic interactions with WDR5. Similar to MLL1~Win~, the P~−2~ to P~+2~ region folds as a 3~10~ helix in which the side chains of P~−3~, P~−2~ and P~−1~ residues pack tightly within WDR5 peptidyl-arginine-binding cleft and make hydrophobic contacts with Ala-65, Gly-89, Ile-90 and Asp-107 side chains. The same residues in WDR5 form a wall that maintains the side chain of the P~−2~ residue in an orientation permissive to make a hydrogen bond with the backbone amide of the P~+1~ residue. The alanine residue in the P~−1~ position binds analogously in all WDR5--Win complexes. Indeed, the P~−1~ amide group engages in a hydrogen bond with the Asp-107 carboxylate group and its side chain makes hydrophobic contacts with the side chains of Phe-133 and Phe-149. Similar to histone H3 R2 ([@gkr1235-B35],[@gkr1235-B40; @gkr1235-B41; @gkr1235-B42]) and MLL1 R3765 ([@gkr1235-B30],[@gkr1235-B31]), the central arginine (P~0~) of the Win motifs extends inside the central toroid cavity of WDR5 in which its guanidinium group interacts with the side chains of Phe-133 and Phe-263. The P~0~ residue also makes several direct hydrogen bonds with the main chains of Ser-91, Phe-133 and Cys-261 and a water-mediated hydrogen bond with the Ser-175 backbone carbonyl group. Following the central arginine residue, the P~+1~ position is occupied by a small residue such as serine (MLL2, SET1A and SET1B) or alanine (MLL3 and MLL4) while the P~+2~ position is occupied by a glutamate residue. Consistent with the sequence homology between the P~+1~ and P~+2~ residues, this portion of the Win motifs shares several interactions with WDR5. The P~+1~ residue makes van der Waals contacts with the side chains of Ala-47 and Tyr-260 while in MLL4 the P~+2~ carboxylate moiety makes two additional water-mediated hydrogen bonds with the backbone amides of the P~+3~ and P~−3~ residues. In addition, the hydroxyl group of the MLL2~Win~ and SET1B~Win~ P~+1~ serine residue makes a hydrogen bond with the sulfhydryl group of the P~−2~ cysteine residue.

Despite high sequence homology and analogous binding modes of the P~−3~, P~−2~, P~−1~ and P~0~ residues, structural alignment of the WDR5--Win complexes reveals notable structural differences. In comparison with MLL1Win, the backbone of the MLL2~Win~ and MLL4~Win~ P~−3~ residue is rotate 180°, which results in additional water-mediated and direct hydrogen bonds with WDR5 ([Figure 3](#gkr1235-F3){ref-type="fig"}). This rotation leads to a small structural displacement of the P~−2~ backbone with negligible consequences on the positioning of C5063 (MLL2), S4708 (MLL3), A2509 (MLL4), S1493 (SET1A) and C1883 (SET1B) side chains and their interactions with WDR5. However, in clear contrast to the P~−2~, P~−1~, P~0~, P~+1~ and P~+2~ residues, the P~+3~ to P~+5~ residues adopt divergent orientations. MLL2~Win~ and MLL3~Win~ peptides, which bind analogously to WDR5, interact in such a way that their respective C-termini point towards blade 5 of WDR5 while MLL4~Win~ and MLL1~Win~ adopt a conformation placing their C-terminal ends towards blade 4 of the β-propeller. SET1A~Win~ and SET1B~Win~ peptides bind in an intermediate orientation such that their C-termini are maintained on the surface of blades 4 and 5 of WDR5 ([Figure 2](#gkr1235-F2){ref-type="fig"}A). Given the structural differences adopted by residues succeeding the P~+2~ residue ([Figure 3](#gkr1235-F3){ref-type="fig"}), we purported that each peptide would engage in distinct interactions with WDR5. The backbone of P~+3~ Y2514 of MLL4~Win~, which binds similarly to H3769 of MLL1~Win~, forms direct and water-mediated hydrogen bonds with Asp-172 and Lys-259 carboxylate and carbonyl groups, respectively. In addition, its aromatic ring makes hydrophobic contacts with the side chains of Tyr-191, Pro-173 and Phe-149. In contrast to the solvent exposed P~+4~ L2516, the P~+5~ R2517 side chain is nestled in a small cleft formed by the surface of blade 4 and the loop connecting blades 4 and 5 of WDR5 ([Figure 3](#gkr1235-F3){ref-type="fig"}B). This crevice, which is composed of Tyr-191, Asp-192, Gly-193, Asn-214, Pro-215 and Pro-216, likely orients the R2517 side chain in a permissive orientation to engage in direct hydrogen bonds with the backbone carbonyl groups of Tyr-191 and Asn-214 and van der Waals contacts with Pro-216. Figure 2.Crystal structure of WDR5 in complex with MLL2-4, SET1A and SET1B Win motifs. (**A**) Overall structure of WDR5 (dark gray) showing the seven blades and the relative orientations of MLL2 (yellow), MLL3 (turquoise), MLL4 (green), SET1A (firebrick) and SET1B (cyan) Win motifs. (**B**) Crystal structure of WDR5--MLL4~Win~ complex. Zoomed view of WDR5 peptidyl-arginine-binding cleft in which WDR5 and MLL4 carbon atoms are rendered in gray and green, respectively. (**C**) Crystal structures of WDR5--MLL2~Win~ and WDR5--MLL3~Win~ complexes. MLL2 and MLL3 carbon atoms are highlighted as in (A). (**D**) Crystal structures of WDR5--SET1A~Win~ and WDR5--SET1B~Win~ complexes. SET1A and SET1B carbon atoms are colored as in (A). Water molecules and key hydrogen bonds are depicted as red spheres and orange dash lines, respectively. Figure 3.Comparative analysis Win motif binding modes. (**A**) Superimposition of WDR5-bound MLL1 (beige) and MLL2 (yellow) peptides. (**B**) Overlay of MLL1 (beige) and MLL4 (green) peptides in complex with WDR5 (grey). (**C**) Structural alignment of WDR5--MLL1~Win~ and WDR5--SET1A~Win~ complex in which carbons of the peptides are highlighted as in [Figure 2](#gkr1235-F2){ref-type="fig"}. Residues of WDR5 peptidyl-arginine-binding adopting divergent conformation between the complexes are rendered as pink carbon atoms. Hydrogen bonds and water molecules are rendered as in [Figure 2](#gkr1235-F2){ref-type="fig"}.

Titration analysis revealed that MLL4~Win~ binds ∼37-fold more tightly to WDR5 than the highly homologous MLL1~Win~ peptide ([Figure 1](#gkr1235-F1){ref-type="fig"} and [Table 1](#gkr1235-T1){ref-type="table"}). Owing to the high sequence homology between these two motifs and structural homology between the WDR5-bound MLL1~Win~ and MLL4~Win~ complexes, the differences in binding affinities are seemingly at odds. However, while a comparative analysis of WDR5--MLL1~Win~ and WDR5--MLL4~Win~ complexes reveals that both MLL1~Win~ and MLL4~Win~ P~+4~ residues share extensive interactions with WDR5, it also shows that a water-mediated interaction of the MLL1~Win~ P~+4~ H3769 side chain with the WDR5 Asp-172 carboxylate group is replaced by a direct hydrogen bond between the same residue in WDR5 and the side chain hydroxyl group of MLL4~Win~ P~+4~ Y2514; a difference that presumably explain the dissimilarity between MLL1~Win~ and MLL4~Win~ binding affinities for WDR5.

Owing to the presence of a proline residue in the P~+3~ position of MLL2~Win~ and MLL3~Win~, we postulated that these peptides would bind WDR5 differently than MLL1~Win~ and MLL4~Win~. Consistent with this hypothesis, structural alignment of WDR5--MLL2~Win~ and WDR5--MLL1~Win~ complexes reveals that the C-terminal end of MLL2~Win~ shifts towards the loop preceding β18, resulting in several novel interactions between MLL2~Win~ and WDR5 ([Figure 3](#gkr1235-F3){ref-type="fig"}B). In MLL2~Win~, the P~+3~ P5068 residue makes close van der Waals contacts with the side chains of Lys-259 and Tyr-260. The WDR5 peptidyl-arginine-binding cleft also undergoes notable structural changes. The phenolic side chain of Tyr-191 rotates of 90° positioning its aromatic ring in a near parallel orientation with the P~+4~ lysine residue of MLL2~Win~/MLL3~Win~. In addition, the same lysine residue in MLL2~Win~/MLL3~Win~ forms a novel hydrogen bond with the Lys-259 carbonyl group and hydrophobic contacts with Leu-234. Finally, in contrast to all other Win motifs, the MLL2~Win~ P~+5~ L5071 residue lies within a hydrophobic cleft composed of Pro-216 and Leu-234. Overall, the crystal structure of MLL2~Win~ bound to WDR5 suggests that the P~+3~ residue acts as a structural determinant underlying the binding mode of a peptide within WDR5 peptidyl-arginine-binding cleft.

After observing that the P~+3~ position in MLL2~Win~/MLL3~Win~ peptides is a key point of structural divergence between the Win peptides, we postulated that the P~+3~ glycine residue of SET1A~Win~/ SET1B~Win~ motifs would also exhibit structural differences compared to other Win motifs. Accordingly, in contrast to MLL1-4 Win peptides, the backbone carbonyl of the SET1A~Win~ P~+2~ glutamate residue undergoes a 180° rotation that results in novel hydrogen bonds between the amide groups of the P~+3~ and P~+4~ residues and the backbone carbonyls of the P~−1~ residue and Lys-259 of WDR5, respectively. Notably, in comparison with the WDR5--MLL1~Win~ complex, the side chains of Lys-259 and Tyr-191 shift toward the Win peptides, which results in the formation of additional hydrophobic contacts with the SET1A~Win~ P~+3~ glycine and P~+5~ tyrosine residues ([Figure 3](#gkr1235-F3){ref-type="fig"}C). In addition, the same tyrosine residue in SET1A engages in several hydrophobic contacts with the lateral chain of Leu-234 and Pro-216.

Overall, the crystal structures of the WDR5--Win complexes highlight WDR5\'s ability in binding the Win motifs using alternative structural determinants. More importantly, our structural studies suggest that the plasticity of WDR5 peptidyl-arginine-binding cleft stems from its ability to operate subtle but key structural changes that accommodate the binding of structurally divergent residues in position P~+3~. Finally, crystal structures of the WDR5--Win complexes suggest that the type of residue at the P~+3~ position will likely play an important role in the binding mode adopted by the peptide within the WDR5 peptidyl-arginine-binding cleft.

Role of WDR5 in stimulating the KMT activity of the SET1 family of methyltransferases
-------------------------------------------------------------------------------------

The Win motif of MLL1 is important for its interaction with the WDR5--RbBP5--ASH2L complex and thereby stimulation of its methyltransferase activity ([@gkr1235-B23]). After showing that WDR5 binds the Win motifs of MLL1-4 and SET1A/B, we examined the role of the WDR5--RbBP5--ASH2L complex in stimulating the other members of the SET1 family of methyltransferases. A comparison of SET1 KMT activity in the absence or presence of the WDR5--RbBP5--ASH2L complex confirmed that the core complex enhances the methyltransferase activity of all members, with the exception of MLL5, but with differences in the fold of stimulation. Specifically, the WDR5--RbBP5--ASH2L complex stimulated MLL2/MLL3 and MLL4 activity by ∼52/256- and ∼15-fold, respectively, while co-incubation of SET1A and SET1B with the core complex subunits increased methylation of histone H3 by ∼40- and ∼1290-fold ([Figure 4](#gkr1235-F4){ref-type="fig"}). The stimulatory roles of the core complex on SET1B can be rationalized by the nearly undetectable activity of these KMTases on histone H3 in the absence of the WDR5--RbBP5--ASH2L complex. Overall, these observations support initial *in vivo* data showing that the members of the core complex are critical for global levels of histone H3K4 methylation. Figure 4.Stimulation of the SET1 family of KMTs activity on histone H3 by the core complex. Radiometric methyltransferase assays performed with MLL2 (**A**), MLL3 (**B**), MLL4 (**C**), SET1A (**D**) and SET1B (**E**) either in the absence or presence of WDR5 and the RbBP5--ASH2L complex. Methyltransferase assays were performed at a concentration of enzyme in the linear range of activity of MLL2 (1 µM), MLL3 (0.5 µM), MLL4 (1 µM), SET1A (1 µM) and SET1B (0.5 µM) complexes. Activity is represented as the average of three independent experiments performed in triplicate. Error bars indicate the standard deviation between the assays.

After showing that the core complex subunits stimulate the methyltransferase activity of MLL2-4, SET1A and SET1B, we sought to measure the contribution of WDR5 in the enzymatic activity of the complex ([Figure 4](#gkr1235-F4){ref-type="fig"}). Interestingly, incubation of the ASH2L/RbBP5 heterodimer with each KMT failed to fully stimulate, to various extent, the enzymatic activity of each member of the SET1 family. Specifically, the absence of WDR5 resulted in a 2-fold decrease of activity for SET1A, MLL3 and MLL4, while co-incubation of SET1B and MLL2 with the ASH2L-RbBP5 heterodimer decreased the methylation of histone H3 by 5-fold and 1.5-fold, respectively ([Figure 4](#gkr1235-F4){ref-type="fig"}). Overall, these results clearly demonstrate the importance of WDR5 in stimulating the methyltransferase activity of MLL2-4, SET1A and SET1B and support recent studies suggesting that WDR5 is key for the activity for all members of the SET1 family of KMTs.

Following the identification that the WDR5--RbBP5--ASH2L complex stimulates all members of the SET1 family, we sought to evaluate the methylation of histone H3 by MLL1-4 in the absence of the core complex subunits. To examine the catalytic activity of each MLL, we incubated each KMT with a histone H3 peptide and a tritiated cofactor. As shown in [Figure 5](#gkr1235-F5){ref-type="fig"}, we failed to detect histone H3 methylation by MLL1, MLL2 and MLL4 while a similar assay performed with MLL3 resulted in a notable accumulation of the methylated peptide. These observations suggest that MLL3 enzymatic activity may play a role independent of the WDR5--RbBP5--ASH2L complex. Figure 5.MLL3 methylates histone H3 in the absence of the core complex subunits. Comparative analysis of MLL\'s enzymatic activity in the absence of the core complex subunits. Assays were performed in the presence of 5.0 µM of enzymes. Activity is represented as in [Figure 4](#gkr1235-F4){ref-type="fig"}.

DISCUSSION
==========

The results presented herein provides biochemical and structural evidence that the WDR5 peptidyl arginine-binding cleft is important in the binding of all the members of the SET1 family of methyltransferases stimulated by the core complex.

Of interest, we observed that MLL2 and MLL3 Win motifs bind similarly to WDR5. Owing to the presence of a proline residue in P~+3~, Song *et al*. ([@gkr1235-B30]) had previously proposed that MLL2/MLL3 might interact with WDR5 using a different mode of binding. Comparative analyses of WDR5--MLL2~Win~ and WDR5--MLL1~Win~ complexes support this hypothesis as the C-terminal ends of each peptide are maintained by specific sets of hydrogen bonds, hydrophobic contacts and van der Waals interactions. Similarly, we also observed noticeable differences between WDR5--SET1A~Win~ and WDR5--MLL1~Win~ complexes that include rotation of the SET1A~Win~ P~+2~ backbone, a change that could be attributed to the presence of a glycine residue in P~+3~, which results in reorientation of the P~+4~ and P~+5~ residues. These structural differences are accommodated by the reorganization of residues forming the WDR5 peptidyl-arginine-binding cleft including Lys-259 and Tyr-191. Although, it was evidenced by several mutational studies ([@gkr1235-B23],[@gkr1235-B28],[@gkr1235-B30],[@gkr1235-B33],[@gkr1235-B35],[@gkr1235-B41]) that the N-terminal end of the Win motifs is important for binding to WDR5, our comparative analysis suggest that the propensity of WDR5 in binding the members of the SET1 family of KMTs is achieved by the plasticity of its peptidyl-arginine-binding cleft and more specifically its ability to accommodate the divergent C-terminal region of the Win motifs.

In metazoans, WDR5 plays a critical role in regulating/maintaining proper levels of histone H3K4 methylation ([@gkr1235-B21],[@gkr1235-B22],[@gkr1235-B24]) while in *Drosophila*, deletion of the will die slowly protein (WDR5 homolog) leads to global loss of methylation and ultimately to lethality ([@gkr1235-B43]). Similarly, morpholino knockdown of WDR5 in *Xenopus* leads to severe developmental deficiencies including gut, hematopoietic and somatic defects ([@gkr1235-B21]). We propose that the plasticity of the WDR5 peptidyl-arginine-binding cleft plays an important role in scaffolding all of the SET1 complexes and underlies the fundamental roles of WDR5 in regulating various developmental programs ([@gkr1235-B21],[@gkr1235-B44]).

MLL3, a unique member of the SET1 family of HKMTs
-------------------------------------------------

The characterization of SET1 enzymatic activity on histone H3 presented herein provides the first comparative analysis for the SET1 family of methyltransferases. While the SET domains of MLL1, MLL2, and MLL4 displayed negligible enzymatic activity in the absence of the WDR5--RbBP5--ASH2L complex, we observed detectable histone H3 methyltransferase activity for MLL3 independent of the core complex. This observation that MLL3 efficiently methylates histone H3 in the absence of the core complex while MLL2 (MLL4 in rodents) strictly depends on the presence of the core complex subunits is interesting. Indeed, while initial studies had suggested that MLL3 and MLL4 are functionally redundant in retinoic acid receptor transactivation in mouse embryonic fibroblasts ([@gkr1235-B45]), targeted inactivation of MLL3 resulted in several defects including lower body mass, hypofertility and increased formation of ureter epithelial tumors ([@gkr1235-B45],[@gkr1235-B46]). Based on our findings, we propose that the ability of MLL3 to methylate histone H3 in the absence of the core complex subunits may underlie some of the non-overlapping functions between MLL3 and MLL4.

The expanding role of WDR5
--------------------------

The recent findings that WDR5 binds to proteins unrelated to the trithorax group proteins shed new light on the ever-expanding role of WDR5. It has been shown recently that Oct4 forms a complex with WDR5 independent of the presence of RbBP5, ASH2L or the SET1 family members ([@gkr1235-B44]). By identifying an interaction between WDR5 and the embryonic stem cell core transcriptional network, the authors of this study established that WDR5 expression is necessary for the efficient formation of induced pluripotent stem cells ([@gkr1235-B44]). In addition, Gan *et al*. ([@gkr1235-B47]), recently demonstrated that WDR5 regulates smooth muscle cell-selective gene activation by interacting with the homeodomain of pituitary homeobox 2. Similarly, WDR5 has been shown to interact with the VISA-associated signaling complex during virus infection-triggered IRF3 and NF-κB activation ([@gkr1235-B48]) and with the NRC/NCoA6 interacting factor 1 ([@gkr1235-B49]). Finally, recent MudPit analysis identified WDR5 as a subunit of the non-specific lethal complex ([@gkr1235-B50]). These examples further emphasize the important role of WDR5 in scaffolding these complexes and we propose that the plasticity of WDR5 peptidyl-arginine-binding cleft, or its recently characterized V-shape cleft ([@gkr1235-B29]), plays an important role in these biological processes.
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================

Coordinates and structure factors for the WDR5-MLL2Win, WDR5-MLL3Win, WDR5-MLL4Win, WDR5-SET1AWin, WDR5-SET1BWin complexes have been deposited in the protein data bank (rcsb.org) with the accession number 3UVK.pdb, 3UVL.pdb, 3UVM.pdb, 3UVN.pdb and 3UVO.pdb respectively.

SUPPLEMENTARY DATA
==================

[Supplementary Data](http://nar.oxfordjournals.org/cgi/content/full/gkr1235/DC1) are available at NAR Online: Supplementary Table 1 and Supplementary Figure 1.

FUNDING
=======

Canadian Institute of Health Research grant (to J.-F.C.); an early research award from the Ministry of Research and Innovation (province of Ontario). Dr Couture holds a Canada Research Chair in Structural Biology and Epigenetics. Natural Sciences and Engineering Research Council of Canada (CREATE) (scholarship to P.Z.). Funding for open access charge: Canadian Institute of Health Research grant (to J.-F.C.); an early research award from the Ministry of Research and Innovation (province of Ontario).

*Conflict of interest statement*. None declared.

Supplementary Material
======================

###### Supplementary Data

We would like to thank Dr Alain Doucet, Sylvain Lanouette and Vanessa Mongeon for providing comments on the manuscript.

[^1]: Underlined residues have not been modeled in the crystal structure. !, C4708S substituted peptide.

[^2]: ^a^Side chain is missing.
